Pappas, P. G., Vazquez, J. A., Oren, I., Rahav, G., aoun, m., Bulpa, P., & Ferrer, R. (2023). Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: Results from a Phase 2 trial.
Chicago Style CitationPappas, Peter G., Jose A. Vazquez, Ilana Oren, Galia Rahav, mickael aoun, Pierre Bulpa, and Ricard Ferrer. Clinical Safety and Efficacy of Novel Antifungal, Fosmanogepix, for the Treatment of Candidaemia: Results From a Phase 2 Trial. 2023.
MLA CitationPappas, Peter G., et al. Clinical Safety and Efficacy of Novel Antifungal, Fosmanogepix, for the Treatment of Candidaemia: Results From a Phase 2 Trial. 2023.
Warning: These citations may not always be 100% accurate.